By Natalie Lo ‘21

Hepatocellular Carcinoma (HCC) is a common form of liver cancer and is possibly related to an infection of hepatitis B virus (HBV) since it can result in cancer formation through activation of oncogenic proteins, inflammation, and cirrhosis. Through a symbiotic relationship, microorganisms in the gut interact with organs in humans, such as the liver, and play an important role in nutrition and immunology. No previous studies have shown a difference between the gut microbiota of patients with HCC related to those of HBV (B-HCC). This unknown difference has captured the attention of Qisha Liu and scientists at the Nanjing Medical University in China.
Hepatocellular Carcinoma (HCC) is a common form of liver cancer and is possibly related to an infection of hepatitis B virus (HBV) since it can result in cancer formation through activation of oncogenic proteins, inflammation, and cirrhosis. Through a symbiotic relationship, microorganisms in the gut interact with organs in humans, such as the liver, and play an important role in nutrition and immunology. No previous studies have shown a difference between the gut microbiota of patients with HCC related to those of HBV (B-HCC). This unknown difference has captured the attention of Qisha Liu and scientists at the Nanjing Medical University in China.
The researchers concluded that there is a difference between patients with B-HCC and NBNC-HCC, and this difference plays a role in the formation of tumors. This study provides crucial information regarding a potential prevention and treatment for the progression of liver disease by monitoring the different microbiomes in patients and potentially altering the gut microbiota of HCC patients as immunotherapy.
References
- Q. Liu, et. al., Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma. Gut pathog 11, 1-13 (2019). doi: 10.1186/s13099-018-0281-6.
- Image retrieved from: https://www.naturalhealth365.com/microbiome-gut-inflammation-1857.html